期刊
CANCER CELL
卷 38, 期 5, 页码 594-597出版社
CELL PRESS
DOI: 10.1016/j.ccell.2020.10.006
关键词
-
资金
- JPB Foundation
- Steven AMP
- Alexandra Cohen Foundation
- Open Philanthropy Project [2020-215611]
- NCI
- Serological Sciences Network (SeroNet)
- National Cancer Institute, National Institutes of Health [75N91019D00024, 75N91020F00003]
Coronavirus disease 2019 (COVID-19), like cancer, is a complex disease with clinical phases of progression. Initially conceptualized as a respiratory disease, COVID-19 is increasingly recognized as a multi-organ and heterogeneous illness. Disease staging is a method for measuring the progression and severity of an illness using objective clinical and molecular criteria. Integral to cancer staging is metastasis,'' defined as the spread of a disease-producing agent, including neoplastic cells and pathogens such as certain viruses, from the primary site to distinct anatomic locations. Staging provides valuable frameworks and benchmarks for clinical decision-making in patient management, improved prognostication, and evidence-based treatment selection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据